Maria Ruderman Singer, a director at Universal Health Services Inc. (NYSE:UHS), has recently sold shares of the company's Class B Common Stock. The transaction, which took place on December 11, involved the sale of 1,614 shares at an average price of $191.1497 per share, totaling approximately $308,515. The healthcare services provider, currently valued at $12.29 billion, has shown strong performance with a 25.62% year-to-date return and trades at an attractive P/E ratio of 12.24.
In addition to the sale, Singer also exercised options to purchase 5,000 shares of Class B Common Stock at a price of $67.69 per share. Following these transactions, Singer owns a total of 5,879 shares directly. According to InvestingPro, UHS maintains a perfect Piotroski Score of 9, indicating excellent financial strength, while management has been actively buying back shares.
These transactions were disclosed in a Form 4 filing with the Securities and Exchange Commission. For deeper insights into UHS's valuation and 8 additional key ProTips, check out the comprehensive Pro Research Report available on InvestingPro.
In other recent news, Universal Health Services (UHS) has experienced a series of analyst adjustments following its recent earnings report. TD Cowen reduced the stock's price target from $275.00 to $251.00, maintaining a Buy rating, while expressing confidence in UHS's potential despite potential policy shifts. BofA Securities downgraded UHS from a Buy to a Neutral rating and adjusted the stock target to $223 due to potential risks. KeyBanc Capital Markets maintained its Sector Weight rating on the shares, and Cantor Fitzgerald raised its price target for the company to $227.00.
Simultaneously, UHS has announced a cash dividend of $0.20 per share, reflecting its continued commitment to shareholders. The company has also reported a net income of $3.80 per diluted share and an 8.6% revenue growth.
In the midst of these developments, UHS is planning facility openings in Las Vegas, D.C., and Florida, projecting a 6% to 7% revenue growth in acute care and mid-to-upper single-digit revenue growth in the behavioral health segment in 2025. These recent developments highlight the ongoing activity and strategic planning at UHS.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.